China and Sri Lanka are set to deepen their bilateral “vaccine diplomacy” with a leading Chinese pharma company preparing to set up a manufacturing plant to make anti-Covid jabs in President Gotabaya Rajapaksa’s home district, Hambantota.
The new plant will be set up under an agreement that will allow Colombo to source nine million Covid-19 vaccine doses from the Chinese pharma company that sets it up, Sri Lankan ambassador to China, Palitha Kohona.
A deal between Sri Lanka’s State Pharmaceutical Corporation (SPC), a state-owned enterprise, and China’s Sinovac Biotech is “fairly close to completion,” Kohana said.
The Sinovac vaccine is one of the two Chinese jabs approved by the World Health Organization (WHO) under its “emergency-use listing”; the other being from state-owned Sinopharm.
No comments:
Post a Comment